Background Image
Previous Page  163 / 182 Next Page
Information
Show Menu
Previous Page 163 / 182 Next Page
Page Background

162

http://www.DGS-PraxisLeitlinien.de

Nr.

Nachweis

124

Hanks GW, Conno F, Cherny N, Hanna M, Kalso E, McQuay HJ, Mercadante S, Meynadier

J, Poulain P, Ripamonti C, Radbruch L, Casas JR, Sawe J, Twycross RG, Ventafridda V; Ex-

pert Working Group of the Research Network of the European Association for Palliative

Care. Morphine and alternative opioids in cancer pain: the EAPC recommendations.

British Journal of Cancer 2001; 84: 587-593.

125

Hanks GW, Nugent M, Higgs CM, Busch MA; OTFC Multicentre Study Group. Oral trans-

mucosal fentanyl citrate in the management of breakthrough pain in cancer: an open,

multicentre, dose-titration and long-term use study. Palliat Med 2004; 18 (8): 698-704.

126

Hansen MS, Mathiesen O, Trautner S, Dahl JB. Intranasal fentanyl in the treatment of

acute pain - a systematic review. Acta Anaesthesiol Scand 2012; 56(4): 407-419.

127

Harbour R, Miller J. A new system for grading recommendations in evidence based

guidelines. British Medical Journal 2001; 323: 334-336.

128

Hassenbach SJ, Cherny NI. neurosurgical approaches in palliative care. In: Doyle D,

Hanks G, Cherny N, Calman K (Hrsg.), Oxford Textbook of Palliative Medicine (3. Aufl.,

396-405). Oxford: Oxford University Press, 2005.

129

Haugen DF, Hjermstad MJ, Hagen N, Caraceni A, Kaasa S. European Palliative Care

Research Collaborative (EPCRC) assessment and classification of cancer breakthrough

pain: a systematic literature review. Pain 2010; 149: 476-482.

130

Herd D, Borland M. Intranasal fentanyl paediatric clinical practice guidelines. Emerg

Med Australas 2009; 21(4): 335.

131

Herr KA, Mobily PR. Comparison of selected pain assessment tools for use with the

elderly. Applied Nursing Research 1993; 6: 39-46.

132

Hicks F, Simpson KH. Nerve blocks in palliative care. Oxford, Oxford University Press,

2004.

133

Howell J. Pharmacotherapy for breakthrough cancer pain. Drugs 2012; 72(7): 1009-

1010.

134

Hwang SS, Chang VT, Kasimis B. Cancer breakthrough pain characteristics and respon-

ses to treatment at a VA medical center. Pain 2003; 101(1-2): 55-64.

135

Ilias W, Gustorff B, Kress HG et al. Empfehlungen zur Behandlung von Durchbruch-

schmerz unter besonderer Berücksichtigung neuer Applikationsformen - Konsensus-

Statement der österreichischen Schmerzgesellschaft. Schmerz-Nachrichten - Zeitschrift

der Österreichischen Schmerzgesellschaft 2010.

136

Intranasal fentanyl versus placebo for pain in children during catheterization for voiding

cystourethrography. Pediatr Radiol 2010; 40(7): 1236-1240

137

Ischia S, Ischia A, Luzzani A, Toscano D, Steele A. Results up to death in the treatment

of persistent cervicao-thoracic (Pancoast) and thoracic malignant pain by unilateral

percutaneous cervical cordotomy. Pain 1985; 21: 339-355.

138

Israel FJ, Parker G, Charles M, Reymond L. Lack of benefit from paracetamol (acetami-

nophen) for palliative cancer patients requiring high-dose strong opioids: a randomized,

double-blind, placebo-controlled, crossover trial. J Pain Symptom Manage 2010; 39(3):

548-554.

Literaturverzeichnis